FDA Adverse Event Injury Summary report: N

VERCISE? CARTESIA? X

MDR report key: 23754015 · Received December 9, 2025

Report

Report Number
3006630150-2025-11281
Event Type
Injury
Date Received
December 9, 2025
Date of Event
November 14, 2025
Report Date
December 9, 2025
Manufacturer
BOSTON SCIENTIFIC NEUROMODULATION CORPORATION
Product Code
PJS
UDI-DI
08714729966340
PMA / PMN Number
P150031
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
WA, US
Reporter Occupation
PHYSICIAN
Health Professional
Yes

Narratives

Additional Manufacturer Narrative · 0

ADDITIONAL SUSPECT MEDICAL DEVICE COMPONENTS INVOLVED IN THE EVENT: PRODUCT FAMILY: DBS-LINEAR LEADS, UPN: M365DB2203450, MODEL: DB-2203-45, SERIAL: (B)(6), BATCH: 5002764, UDI: (B)(4). PRODUCT FAMILY: DBS-EXTENSION UPN: M365DB3216550, MODEL: DB-3216-55, SERIAL: (B)(6), BATCH: 5001273, UDI: (B)(4). PRODUCT FAMILY: DBS-EXTENSION UPN: M365DB3216550, MODEL: DB-3216-55, SERIAL: (B)(6), BATCH: 5001298, UDI: (B)(4).

Description of Event or Problem · 0

IT WAS REPORTED THAT THE DEEP BRAIN STIMULATION (DBS) PATIENT UNDERWENT AN EXPLANT PROCEDURE OF THE ENTIRE SYSTEM DUE TO INFECTION. THE PATIENT SUFFERED A VASOVAGAL SYNCOPE AT HOME, NOT RELATED TO STIMULATION OR THE DEVICE, AND SUSTAINED A HEAD INJURY AS A RESULT OF THE FALL. THE WOUND WAS LOCATED IN THE AREA OF THE LEAD/LEAD EXTENSION JUNCTURE AND SUBSEQUENTLY BECAME INFECTED. THE SYMPTOMS THE PATIENT EXPERIENCED INCLUDED REDNESS, SWELLING, AND FLUID DISCHARGE. THE PATIENT WAS PLACED ON AN ANTIBIOTIC REGIMEN; HOWEVER, THE SURGEON DETERMINED THAT EXPLANTATION OF THE DEVICE WAS NECESSARY. THE PATIENT IS RECOVERING NORMALLY FOLLOWING THE EXPLANT PROCEDURE. THE EXPLANTED DEVICES WERE DISPOSED OF BY THE HOSPITAL AND WILL NOT BE RETURNED TO BOSTON SCIENTIFIC FOR ANALYSIS.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
2813832 VERCISE? CARTESIA? X STIMULATOR, ELECTRICAL, IMPLANTED, FOR PARKINSONIAN SYMPTOMS PJS BOSTON SCIENTIFIC NEUROMODULATION CORPORATION DB-2203-45 5003337 08714729966340

Patients

Seq Age Sex Outcome Treatment
1 49 YR Female Required Intervention